Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project

Impairment of Pulmonary Function is an Independent Risk Factor for Atrial Fibrillation: The Takahata Study

(2012) Yoko Shibata et al.   International Journal of Medical Sciences

Lung Function as a Risk Factor for Subarachnoid Hemorrhage

(2012) Martin Söderholm et al.   STROKE

Predictors of incident atrial fibrillation and influence of medications: a retrospective case–control study

(2011) James A Hodgkinson et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors

(2011) Rachel R. Huxley et al.   CIRCULATION

The use of long acting β2-agonists, alone or in combination with inhaled corticosteroids, in Chronic Obstructive Pulmonary Disease (COPD)

(2011) Alison C. Cave et al.   PHARMACOLOGY & THERAPEUTICS

Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: Implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea

(2010) Irene H. Stevenson et al.   HEART RHYTHM

Progression From Paroxysmal to Persistent Atrial Fibrillation

(2010) Cees B. de Vos et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

BP Variability and Cardiovascular Autonomic Function in Relation to Forced Expiratory Volume

(2009) Gunnar Engström et al.   CHEST

Prevention of Atrial Fibrillation

(2009) Emelia J. Benjamin et al.   CIRCULATION

Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity

(2009) J. Gustav Smith et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Arrhythmias in Patients With Chronic Obstructive Pulmonary Disease (COPD)

(2008) John P. Hanrahan et al.   MEDICINE